51 related articles for article (PubMed ID: 7039203)
1. Intestinal pharmacomanometry and glucose tolerance: two kinds of dopaminergic mechanisms in the human.
Lechin F; van der Dijs B
Acta Gastroenterol Latinoam; 1981; 11(2):247-59. PubMed ID: 7039203
[TBL] [Abstract][Full Text] [Related]
2. Intestinal pharmacomanometry and glucose tolerance: evidence for two antagonistic dopaminergic mechanisms in the human.
Lechin F; van der Dijs B
Biol Psychiatry; 1981 Oct; 16(10):969-86. PubMed ID: 7306619
[TBL] [Abstract][Full Text] [Related]
3. Effects of dopaminergic blocking agents on distal colon motility.
Lechin F; Van Der Dijs B
J Clin Pharmacol; 1979 Oct; 19(10):617-25. PubMed ID: 512059
[TBL] [Abstract][Full Text] [Related]
4. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
Dhir A; Kulkarni SK
Brain Res Bull; 2007 Sep; 74(1-3):58-65. PubMed ID: 17683790
[TBL] [Abstract][Full Text] [Related]
5. [Effect of prokinetic drugs inhibiting dopaminergic system on gallbladder motility in subjects with duodenal ulcer].
Szabelska K; Chojnacki J; Grzegorczyk K; Mamos A
Pol Merkur Lekarski; 1999 Apr; 6(34):188-91. PubMed ID: 10391057
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic mechanisms in the conditioned and unconditioned fear as assessed by the two-way avoidance and light switch-off tests.
Reis FL; Masson S; de Oliveira AR; Brandão ML
Pharmacol Biochem Behav; 2004 Oct; 79(2):359-65. PubMed ID: 15501313
[TBL] [Abstract][Full Text] [Related]
7. Dopamine: pharmacologic and therapeutic aspects.
Velasco M; Luchsinger A
Am J Ther; 1998 Jan; 5(1):37-43. PubMed ID: 10099036
[TBL] [Abstract][Full Text] [Related]
8. Dopamine-induced protection against indomethacin-evoked intestinal lesions in rats--role of anti-intestinal motility mediated by D2 receptors.
Miyazawa T; Matsumoto M; Kato S; Takeuchi K
Med Sci Monit; 2003 Feb; 9(2):BR71-7. PubMed ID: 12601282
[TBL] [Abstract][Full Text] [Related]
9. Effects of dopamine in isolated rat colon strips.
Aguilar MJ; Estañ L; Martínez-Mir I; Martínez-Abad M; Rubio E; Morales-Olivas FJ
Can J Physiol Pharmacol; 2005 Jun; 83(6):447-52. PubMed ID: 16049543
[TBL] [Abstract][Full Text] [Related]
10. Distal colon motility in schizophrenic patients.
Lechin F; Gômez F; van der Dijs B; Lechin E
J Clin Pharmacol; 1980 Jul; 20(7):459-64. PubMed ID: 6107308
[TBL] [Abstract][Full Text] [Related]
11. Conditioned dopaminergic activity.
Schiff SR
Biol Psychiatry; 1982 Feb; 17(2):135-54. PubMed ID: 7200377
[TBL] [Abstract][Full Text] [Related]
12. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
[TBL] [Abstract][Full Text] [Related]
13. Psychopharmacological profile of amisulpride: an antipsychotic drug with presynaptic D2/D3 dopamine receptor antagonist activity and limbic selectivity.
Perrault G; Depoortere R; Morel E; Sanger DJ; Scatton B
J Pharmacol Exp Ther; 1997 Jan; 280(1):73-82. PubMed ID: 8996184
[TBL] [Abstract][Full Text] [Related]
14. [The participation of the dopaminergic system of the striatum in the regulation of catalepsy in mice and rats of different genotypes].
Skrinskaia IuA; Popova NK; Nikulina EM; Kulikov AV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1997; 47(6):1032-9. PubMed ID: 9472169
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term treatment with haloperidol and sulpiride on different types of dopaminergic receptors.
Trabucchi M; Memo M; Battaini F; Reggiani A; Spano PF
Adv Biochem Psychopharmacol; 1980; 24():275-81. PubMed ID: 7405667
[No Abstract] [Full Text] [Related]
16. [Participation of dopamine on the muscarinergic inhibitory effect of substance P on gastric myoelectric activity and motility].
Jing H; Lin KW; Mei MH
Sheng Li Xue Bao; 1995 Jun; 47(3):245-52. PubMed ID: 7570109
[TBL] [Abstract][Full Text] [Related]
17. Histaminergic receptors of medial septum and conditioned place preference: D1 dopamine receptor mechanism.
Zarrindast MR; Moghimi M; Rostami P; Rezayof A
Brain Res; 2006 Sep; 1109(1):108-16. PubMed ID: 16828718
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and structure-affinity relationships of novel N-(1-ethyl-4-methylhexahydro-1,4-diazepin-6-yl)pyridine-3-carboxamides with potent serotonin 5-HT3 and dopamine D2 receptor antagonistic activity.
Hirokawa Y; Fujiwara I; Suzuki K; Harada H; Yoshikawa T; Yoshida N; Kato S
J Med Chem; 2003 Feb; 46(5):702-15. PubMed ID: 12593651
[TBL] [Abstract][Full Text] [Related]
19. Changes in dopaminergic and glutamatergic excitatory mechanisms of micturition reflex after middle cerebral artery occlusion in conscious rats.
Yokoyama O; Yoshiyama M; Namiki M; de Groat WC
Exp Neurol; 2002 Jan; 173(1):129-35. PubMed ID: 11771945
[TBL] [Abstract][Full Text] [Related]
20. [The role of dopamine in the gastrointestinal tract and its relation to intestinal peptides].
Castells Molina S; Rodríguez Méndez SA
Med Clin (Barc); 1988 Jan; 90(1):28-32. PubMed ID: 3279275
[No Abstract] [Full Text] [Related]
[Next] [New Search]
